STAT gathered reactions from leaders across biotech and pharma about what the new Trump era could mean for them.

While A.I. promises breakthroughs, industry leaders warn that transparency and patient safety must remain front and center.

In the global pharmaceutical industry, there were two private equity deals announced in Q3 2024, worth a total value of $7.5m, according to GlobalData's Deals Database.

As the Minister said, the pharmaceutical industry, through research and innovation, becomes more competitive, more ...

Morocco is one of the key buyers of Russian pharmaceutical products, along with Algeria, Uganda, the Congo, and Nigeria with last year’s value of Russian pharmaceutical exports to Africa reaching ...

In a significant financial move in the pharmaceutical industry, Edwards Life Sciences has sold its Critical Care division to Becton Dickinson (BD) for $4,200 million. The transaction, legally executed ...

With increasing pharmaceutical production and a growing focus on patient safety, the demand for specialized and customizable ...

Teva Pharmaceutical Industries raised its 2024 revenue and earnings guidance on Wednesday after beating third-quarter profit ...

a leading industry group. That’s 25% larger than it was in 2019, making it bigger than the sports and pharmaceutical industries. “Growth was even stronger than we predicted,” says Katherine ...

Despite the relatively low profile, Tianjin Pharmaceutical's improved earnings have earned recognition from investors ...

In the wake of the biggest American political comeback in more than 100 years, stakeholders in the health industry are asking themselves: What ...

In the global pharmaceutical industry, there were three private equity deals announced in Q3 2024, worth a total value of $4.2m, according to GlobalData's Deals Database.